Variant report
Variant | nsv1048247 |
---|---|
Chromosome Location | chr13:87041270-87073440 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:5)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:5 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SLITRK6-13 | chr13:87071264-87071414 | NONHSAT034578 |
2 | lnc-SLITRK6-13 | chr13:87064440-87065323 | l_895_chr13:87064439-87121529_brain |
3 | lnc-SLITRK6-13 | chr13:87065395-87066011 | l_895_chr13:87064439-87121529_brain |
4 | lnc-SLITRK6-13 | chr13:87065819-87066011 | NONHSAT034577 |
5 | lnc-SLITRK6-13 | chr13:87065819-87066011 | NONHSAT034578 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556669328 | chr13:87049423-87049424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs182320689 | chr13:87049460-87049461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs187737575 | chr13:87049475-87049476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575327773 | chr13:87049505-87049506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536327747 | chr13:87049517-87049518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs554710904 | chr13:87049555-87049556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573436226 | chr13:87049614-87049615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540463505 | chr13:87049627-87049628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs537313418 | chr13:87049635-87049636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs565519134 | chr13:87049640-87049641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs370623076 | chr13:87049675-87049676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs577444567 | chr13:87049771-87049772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs544921996 | chr13:87049886-87049887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs562505288 | chr13:87049926-87049927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs530058984 | chr13:87049957-87049958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534236858 | chr13:87050066-87050067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs191075583 | chr13:87050068-87050069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554414177 | chr13:87050104-87050105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs17612602 | chr13:87050126-87050127 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs17650224 | chr13:87050127-87050128 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs546456958 | chr13:87050172-87050173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571455670 | chr13:87050307-87050308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs536386419 | chr13:87050324-87050325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs12874621 | chr13:87050385-87050386 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs550915428 | chr13:87050392-87050393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572847250 | chr13:87050401-87050402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs9518034 | chr13:87050402-87050403 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs577479031 | chr13:87050403-87050404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs183241734 | chr13:87050418-87050419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs551017899 | chr13:87050436-87050437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554647616 | chr13:87050522-87050523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572974310 | chr13:87050533-87050534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188701235 | chr13:87050536-87050537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558866816 | chr13:87050537-87050538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs577381089 | chr13:87050595-87050596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs544547623 | chr13:87050626-87050627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs536627223 | chr13:87050689-87050690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs371175107 | chr13:87050736-87050737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574451595 | chr13:87050838-87050839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs541810425 | chr13:87050888-87050889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs560159959 | chr13:87050910-87050911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs74889127 | chr13:87050989-87050990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs546295616 | chr13:87051099-87051100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs79453265 | chr13:87051164-87051165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs145746246 | chr13:87051189-87051190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs550855974 | chr13:87051198-87051199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs78906424 | chr13:87051210-87051211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs138325502 | chr13:87051239-87051240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs113043555 | chr13:87051273-87051274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs192587550 | chr13:87051302-87051303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Osteosarcoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:87049400-87050000 | Enhancers | Fetal Brain Male | brain |
2 | chr13:87050000-87054600 | Weak transcription | Fetal Brain Male | brain |
3 | chr13:87051400-87052200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr13:87054600-87055600 | Enhancers | Fetal Brain Male | brain |
5 | chr13:87055800-87056400 | Enhancers | Fetal Brain Female | brain |
6 | chr13:87062200-87062400 | Flanking Active TSS | Gastric | stomach |
7 | chr13:87064200-87064400 | Enhancers | H9 Cell Line | embryonic stem cell |
8 | chr13:87064400-87068000 | Weak transcription | H9 Cell Line | embryonic stem cell |
9 | chr13:87066000-87066800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr13:87066000-87067000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr13:87066000-87067000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr13:87066000-87067000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr13:87066200-87066400 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
14 | chr13:87066200-87066600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
15 | chr13:87066200-87066800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
16 | chr13:87066400-87066800 | Enhancers | HUES6 Cell Line | embryonic stem cell |